Skip to main content
. 2015 Nov 27;71(Pt 12):1531–1539. doi: 10.1107/S2053230X15022049

Figure 5.

Figure 5

Protein–ligand interactions across the active sites of plasmepsin II in complexes with hydroxyethylamine-based inhibitors. (a) PMII–NU655, (b) PMII–PG418, (c) PMII–PG394. (d) Wall-eyed stereoview of the superposition of the PMII active site with the three inhibitors.